Baseline

4 weeks

8 weeks

Number of redness Lv. 1

Placebo

337.6 ± 448.8

391.4 ± 401.6

(53.8 ± 240.8)

445.3 ± 390.9

(107.6 ± 332.7)

Delphinol®

596.9 ± 609.3

480.9 ± 623.0

(−116.0 ± 413.8)

548.8 ± 690.5

(−48.1 ± 441.2)

Area of redness Lv. 1

Placebo

223.5 ± 424.5

315.4 ± 513.8

(91.9 ± 177.2)

277.6 ± 363.2

(54.1 ± 192.3)

Delphinol®

393.5 ± 393.6

289.9 ± 274.6

(−103.6 ± 274.9)

336.6 ± 346.8

(−59.9 ± 315.9)

Number of redness Lv. 2

Placebo

36.5 ± 84.4

65.4 ± 115.4

(28.9 ± 46.5)

52.4 ± 73.1

(15.9 ± 51.8)

Delphinol®

64.1 ± 58.9

35.8 ± 30.0

(−28.4 ± 34.9)*

53.9 ± 70.1

(−10.3 ± 43.6)

Area of redness Lv.2

Placebo

11.1 ± 23.6

21.0 ± 39.5

(9.9 ± 17.4)

20.0 ± 36.1

(8.9 ± 16.4)

Delphinol®

20.6 ± 22.2

11.4 ± 11.7

(−9.3 ± 13.3)*

21.4 ± 23.8

(0.8 ± 16.5)

Number of redness Lv. 3

Placebo

0.9 ± 2.1

2.0 ± 3.4

(1.1 ± 1.7)

4.1 ± 7.1

(3.3 ± 5.4)

Delphinol®

2.4 ± 4.2

1.6 ± 2.6

(−0.8 ± 1.8)

4.5 ± 7.3

(2.1 ± 3.8)

Area of redness Lv. 3

Placebo

0.1 ± 0.4

0.4 ± 1.1

(0.3 ± 1.2)

0.6 ± 1.1

(0.5 ± 1.2)

Delphinol®

1.6 ± 3.1

0.9 ± 2.1

(−0.8 ± 1.5)

1.8 ± 3.8

(0.1 ± 1.6)